Skip to main content

Advertisement

SpringerLink
Log in

Long-term outcome following Thulium VapoEnucleation of the prostate

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction

To evaluate Thulium VapoEnucleation of the prostate (ThuVEP) for patients with symptomatic benign prostatic obstruction (BPO) with long-term follow-up.

Methods

A prospective analysis of 124 patients who underwent ThuVEP between January 2007 and July 2008 at our institution was done. ThuVEP was carried out using the 70-Watt 2-μm continuous wave Tm:YAG laser. Patient demographic, perioperative complications, and follow-up data were analysed.

Results

The median (interquartile range) preoperative prostate volume was 58.5 (45–70.75) cc. The median operation and enucleation time were 74 (60–100) and 32.54 (25.62–37.52) min, respectively. The median catheter time and postoperative hospital stay were 2 (2–2) and 4 (3–5) days, respectively. Nine (7.3 %) patients required a second-look operation in the immediate postoperative course (failed morcellation = 2, clot retention = 3, and residual adenoma = 4). Two patients needed blood transfusions (1.6 %) postoperatively. At 12-month follow-up, International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urinary flow rate (Qmax), and postvoiding residual urine (PVR) improved significantly in comparison with preoperative assessment (p < 0.001). A significant decrease of median PSA (4.7 vs. 0.92 μg/l) was seen at one-year follow-up (p < 0.001). At the 48-month follow-up mark, Qmax, PVR, IPSS, and QoL still differed significantly from baseline (p < 0.001). Bladder neck contractures and urethral strictures each developed in 1.6 and 0.8 % of the patients during follow-up. None of the patients were re-treated during follow-up for recurrent prostatic tissue.

Conclusions

ThuVEP is a safe, efficacious, and durable procedure for the treatment of BPO. The incidence of late complications with ThuVEP was low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek P, Lack N, Stief CG, Reich O (2007) Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 177:1419–1422

    Article  PubMed  Google Scholar 

  2. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180:246–249

    Google Scholar 

  3. Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397

    Article  PubMed  Google Scholar 

  4. Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 109:408–411

    Article  PubMed  Google Scholar 

  5. Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M, Schatzl G; Prostate Study Group of the Austrian Society of Urology (2005) Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47:499–504

    Google Scholar 

  6. Elzayat EA, Habib EI, Elhilali MM (2005) Holmium laser enucleation of the prostate: a size-independent new “gold standard”. Urology. 66:108–113

    Article  PubMed  Google Scholar 

  7. Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 49:87–91

    Article  PubMed  Google Scholar 

  8. Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52:1465–1470

    Article  PubMed  Google Scholar 

  9. Ahyai SA, Lehrich K, Kuntz RM (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 52:1456–1463

    Article  PubMed  Google Scholar 

  10. Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160–166

    Article  PubMed  Google Scholar 

  11. Gilling PJ, Aho TF, Frampton CM, King CJ, Fraunhofer MR (2008) Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 53:744–749

    Article  PubMed  Google Scholar 

  12. Vavassori I, Valenti S, Naspro R, Vismara A, Dell’Acqua V, Manzetti A, Hurle R (2008) Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol 53:599–604

    Article  PubMed  Google Scholar 

  13. Krambeck AE, Handa SE, Lingeman JE (2010) Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 183:1105–1109

    Article  PubMed  Google Scholar 

  14. Elmansy HM, Kotb A, Elhilali MM (2011) Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of follow-up. J Urol 186:1972–1976

    Article  PubMed  Google Scholar 

  15. Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39–43

    Article  PubMed  Google Scholar 

  16. Bach T, Netsch C, Pohlmann L, Herrmann TR, Gross AJ (2011) Thulium:YAG vapoenucleation in large volume prostates. J Urol 186:2323–2327

    Article  PubMed  Google Scholar 

  17. Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T (2014) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63:859–867

    Google Scholar 

  18. Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29:205–210

    Article  PubMed Central  PubMed  Google Scholar 

  19. Netsch C, Bach T, Herrmann TR, Neubauer O, Gross AJ (2013) Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol 31:1231–1238

    Article  CAS  PubMed  Google Scholar 

  20. Malek RS, Kuntzman RS, Barrett DM (2005) Photoselective potassiumtitanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174:1344–1348

    Article  PubMed  Google Scholar 

  21. Te AE, Malloy TR, Stein BS, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 97:1229–1233

    Article  CAS  PubMed  Google Scholar 

  22. Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, Gasser TC, Bachmann A (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893–901

    Article  PubMed  Google Scholar 

  23. Hai M (2009) Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 73:807–810

    Article  PubMed  Google Scholar 

  24. Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, Shokeir AA (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:349–355

    Article  PubMed  Google Scholar 

  25. Elmansy HM, Elzayat E, Elhilali MM (2010) Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. J Urol 184:2023–2028

    Article  PubMed  Google Scholar 

  26. Elshal AM, Elmansy HM, Elhilali MM (2013) Two laser ablation techniques for a prostate less than 60 ml: lessons learned 70 months after a randomized controlled trial. Urology. 82:416–422

    Article  PubMed  Google Scholar 

  27. Malde S, Rajagopalan A, Patel N, Simoes A, Choi W, Shrotri N (2012) Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. J Endourol 26:878–883

    Article  PubMed  Google Scholar 

  28. Mattiasson A, Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, Larson T, Boyle E, Duelund-Jacobsen J, Kroyer K, Ageheim H (2007) Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology. 69:91–96

    Article  PubMed  Google Scholar 

  29. Autorino R, Damiano R, Di Lorenzo G, Quarto G, Perdonà S, D’Armiento M, De Sio M (2009) Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Eur Urol 55:922–929

    Article  PubMed  Google Scholar 

  30. Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C (2004) Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology. 64:306–310

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have nothing to disclose.

Ethical standard

All patients were treated after obtaining informed consent, following institutional review board approval.

Author information

Authors and Affiliations

  1. Department of Urology, Asklepios Hospital Barmbek, Rübenkamp 220, 22291, Hamburg, Germany

    C. Netsch, A. Engbert & A. J. Gross

  2. Department of Urology, Asklepios Hospital Harburg, Hamburg, Germany

    T. Bach

Authors
  1. C. Netsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Engbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Bach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. J. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Netsch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Netsch, C., Engbert, A., Bach, T. et al. Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol 32, 1551–1558 (2014). https://doi.org/10.1007/s00345-014-1260-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-014-1260-2

Keywords

Search

Navigation